396 related articles for article (PubMed ID: 27376752)
1. [Pruritus in systemic diseases : Common and rare etiologies].
Kremer AE; Mettang T
Hautarzt; 2016 Aug; 67(8):606-14. PubMed ID: 27376752
[TBL] [Abstract][Full Text] [Related]
2. [Pruritus in systemic diseases : Common and rare etiologies].
Kremer AE; Mettang T
Internist (Berl); 2019 Aug; 60(8):814-820. PubMed ID: 31243493
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of chronic itch in systemic disease. Current standards].
Mettang T; Ständer S; Kremer AE
Internist (Berl); 2015 Dec; 56(12):1369-78. PubMed ID: 26585238
[TBL] [Abstract][Full Text] [Related]
4. What are new treatment concepts in systemic itch?
Kremer AE
Exp Dermatol; 2019 Dec; 28(12):1485-1492. PubMed ID: 31452276
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis and treatment of pruritus in cholestasis.
Kremer AE; Beuers U; Oude-Elferink RP; Pusl T
Drugs; 2008; 68(15):2163-82. PubMed ID: 18840005
[TBL] [Abstract][Full Text] [Related]
6. Itch Management in the Elderly.
Leslie TA
Curr Probl Dermatol; 2016; 50():192-201. PubMed ID: 27578088
[TBL] [Abstract][Full Text] [Related]
7. Systemic kappa opioid receptor agonists in the treatment of chronic pruritus: a literature review.
Phan NQ; Lotts T; Antal A; Bernhard JD; Ständer S
Acta Derm Venereol; 2012 Sep; 92(5):555-60. PubMed ID: 22504709
[TBL] [Abstract][Full Text] [Related]
8. Emerging drugs for the treatment of pruritus.
Ständer S; Weisshaar E; Raap U
Expert Opin Emerg Drugs; 2015 Sep; 20(3):515-21. PubMed ID: 26027744
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological interventions for pruritus in adult palliative care patients.
Xander C; Meerpohl JJ; Galandi D; Buroh S; Schwarzer G; Antes G; Becker G
Cochrane Database Syst Rev; 2013 Jun; (6):CD008320. PubMed ID: 23749733
[TBL] [Abstract][Full Text] [Related]
10. Kappa-opioid system in uremic pruritus: multicenter, randomized, double-blind, placebo-controlled clinical studies.
Wikström B; Gellert R; Ladefoged SD; Danda Y; Akai M; Ide K; Ogasawara M; Kawashima Y; Ueno K; Mori A; Ueno Y
J Am Soc Nephrol; 2005 Dec; 16(12):3742-7. PubMed ID: 16251241
[TBL] [Abstract][Full Text] [Related]
11. The challenge of cholestatic pruritus.
Bolier AR; Peri S; Oude Elferink RP; Beuers U
Acta Gastroenterol Belg; 2012 Dec; 75(4):399-404. PubMed ID: 23402082
[TBL] [Abstract][Full Text] [Related]
12. Role of Pregabalin in Management of Pruritus: A Literature Review.
Foroutan N; Nikvarz N
J Pharm Pharm Sci; 2016; 19(4):465-474. PubMed ID: 28057164
[TBL] [Abstract][Full Text] [Related]
13. Itch Management: Treatments under Development.
Pereira MP; Ständer S
Curr Probl Dermatol; 2016; 50():71-6. PubMed ID: 27578074
[TBL] [Abstract][Full Text] [Related]
14. [Uremic pruritus: an unresolved challenge].
Aucella F; Gesuete A
G Ital Nefrol; 2009; 26(5):585-99. PubMed ID: 19802804
[TBL] [Abstract][Full Text] [Related]
15. Uremic pruritus.
Mettang T; Kremer AE
Kidney Int; 2015 Apr; 87(4):685-91. PubMed ID: 24402092
[TBL] [Abstract][Full Text] [Related]
16. Antipruritic treatment with systemic μ-opioid receptor antagonists: a review.
Phan NQ; Bernhard JD; Luger TA; Ständer S
J Am Acad Dermatol; 2010 Oct; 63(4):680-8. PubMed ID: 20462660
[TBL] [Abstract][Full Text] [Related]
17. Use of Butorphanol as Treatment for Cholestatic Itch.
Golpanian RS; Yosipovitch G; Levy C
Dig Dis Sci; 2021 May; 66(5):1693-1699. PubMed ID: 32556969
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis and Management of Pruritus in PBC and PSC.
Kremer AE; Namer B; Bolier R; Fischer MJ; Oude Elferink RP; Beuers U
Dig Dis; 2015; 33 Suppl 2():164-75. PubMed ID: 26641452
[TBL] [Abstract][Full Text] [Related]
19. Antidepressants as antipruritic agents: A review.
Kaur R; Sinha VR
Eur Neuropsychopharmacol; 2018 Mar; 28(3):341-352. PubMed ID: 29456150
[TBL] [Abstract][Full Text] [Related]
20. Clinical evaluation of generalized pruritus.
Sher TH
Compr Ther; 1992 Sep; 18(9):14-9. PubMed ID: 1424535
[No Abstract] [Full Text] [Related]
[Next] [New Search]
